REDWOOD CITY, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced that management will participate in the following upcoming investor conferences: Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumFormat: Fireside chat and 1x1 meetingsDate: Wednesday, November 11Fireside Chat Time: 9:30 AM – 9:55 AM ET Stifel 2026 Healthcare ConferenceFormat: Fire
Pulmonx (NASDAQ:LUNG) shares fell 10. 1% to $2.
REDWOOD CITY, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (the “Company” or “Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that on September 1, 2026 (the “Grant Date”), Pulmonx granted equity awards under its 2025 Inducement Plan (the “Inducement Plan”) to four individuals hired by Pulmonx in the third fiscal quarter of 2026. The awards were approved by the Compensation Committee of the Company’s Board of Directors
REDWOOD CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced that management will participate in the following upcoming investor conferences: Wells Fargo Healthcare ConferenceFormat: 1x1 meetingsDate: Wednesday, September 9Location: Boston, MA Lake Street Best Ideas Growth (BIG10) ConferenceFormat: 1x1 meetingsDate: Thursday, September 10Location: New York, NY About
Is it a good or bad thing when a stock experiences a golden cross technical event?
This is the newest page. Registered accounts read further back.